What is Haemonetics's long-term debt?

Haemonetics (HAE) reported long-term debt of $1.22B in Q1 2026.

How has Haemonetics's long-term debt changed year-over-year?

Haemonetics's long-term debt increased by 32.4% year-over-year, from $921.23M to $1.22B.

What is the long-term trend for Haemonetics's long-term debt?

Over 5 years (2021 to 2026), Haemonetics's long-term debt has grown at a 12.0% compound annual growth rate (CAGR), from $690.59M to $1.22B.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Haemonetics HAE Long-Term Debt

Long-Term Debt at other companies

AbbottABT

$29.64B+133%

TFX

TeleflexTFX

$2.51B+39.1%

MedtronicMDT

$26.17B+2.1%

LivaNovaLIVN

$285.16M-48.1%

ICU MedicalICUI

$1.28B-16.6%

Merit Medical SystemsMMSI

$735.16M+0.6%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's long-term debt?: Haemonetics (HAE) reported long-term debt of $1.22B in Q1 2026.
How has Haemonetics's long-term debt changed year-over-year?: Haemonetics's long-term debt increased by 32.4% year-over-year, from $921.23M to $1.22B.
What is the long-term trend for Haemonetics's long-term debt?: Over 5 years (2021 to 2026), Haemonetics's long-term debt has grown at a 12.0% compound annual growth rate (CAGR), from $690.59M to $1.22B.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.